- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06343324
Effect of Web-Based Adaptation and Insomnia Severity in Individuals Using Noninvasive Ventilators at Home
The Effect of Web-Based "NIV Living Training" on NIV Compliance and Insomnia Severity in Individuals Using Noninvasive Ventilators (NIV) at Home: Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Support will be received from a software expert in mobile application development. The Mobile Application will be given the short name "Breathe", which indicates that it is an application application. The mobile application is planned to consist of 7 interfaces. 1.Interface: Training on Living with NIV - Password and Information General information about Living with NIV Training will be included. It is an interface where individuals can log in to the system with their password and information.
2.Interface: What is BIPAP? This interface will include general information about individuals' intended use of NIV, what it does, and how to select equipment.
3.Interface: Maintenance and cleaning of the device This interface will contain information on when and how the NIV device and equipment should be cleaned.
4.Interface: Most frequently asked questions about BIPAP treatment This interface will include the problems that individuals frequently experience when using NIV and tips on how to solve these problems.
Interface 5: Insomnia and coping methods This interface will contain information about insomnia and what techniques to use to cope with insomnia. It will also include sleep exercise to help you fall asleep.
6.Interface: Trainings This interface; It will consist of educational content such as breathing exercise, lung cleaning technique, breathing control in daily life activities (walking, bathing, climbing stairs, etc.), personal hygiene and dressing, and communication and special situations while using NIV.
7.Interface: Communication It is an interface where individuals can communicate with the researcher and ask questions.
Individuals assigned to the experimental group Individuals in the experimental group will be informed about the mobile application. The web-based mobile application called "Training for Living with NIV" prepared by the researcher will be installed on the mobile phone of the individual or his caregiver. They will be asked to log in to the web-based "NIV Living Training" mobile application once a week to consolidate their knowledge, and text message alerts will be sent via mobile phone. S³-NIV Questionnaire and ISI forms will be applied to the experimental group again in the first week, 4th week and 8th week.
Individuals assigned to the control group Written educational material was sent to individuals in the control group. S³-NIV Questionnaire and ISI forms will be applied again to the control group in the first week, 4th week and 8th week. After the 8th week data collection, web-based "NIV Survival Training" will also be given to individuals in the control group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Selçuklu
-
Konya, Selçuklu, Turkey, 42060
- Health Sciences University Konya Beyhekim Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals who have used NIV at home for at least 4 months or more,
- Individuals between the ages of 50-75,
- No communication barrier,
- Whether the caregiver or the individual himself is using a smart phone,
- Having internet access,
- Ability to read and understand Turkish.
Exclusion Criteria:
- Myocardial infarction or cerebrovascular accident, schizophrenia, etc. in the last 3 months. Individuals who cannot provide their own self-care due to illness,
- Being diagnosed with cancer,
- Being hospitalized with acute exacerbation,
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
Individuals in the experimental group will be informed about the mobile application.
The web-based mobile application called "Training for Living with NIV" prepared by the researcher will be installed on the mobile phone of the individual or his caregiver.
They will be asked to log in to the web-based "NIV Living Training" mobile application twice a week to reinforce their knowledge, and text message alerts will be sent via mobile phone.
Patient Descriptive Characteristics Form, S³-NIV Questionnaire and Insomnia Severity Index scales will be applied to the experimental group as pre-test data.
The scales will be applied again to the experimental group, which continues education for 8 weeks, in the 4th week and the 8th week.
|
Patients using noninvasive ventilation at home will receive detailed information about accessing, logging in and using web-based training.
Pretest data will be collected, then week 4 and week 8 data will be collected.
|
|
No Intervention: Control Group
Written educational material was sent to individuals in the control group.
Patient Descriptive Characteristics Form, S³-NIV Questionnaire and Insomnia Severity Index scales will be applied as pre-test data to the control group, which is not given any training other than written material.
During the 8-week period, the scales will be applied to the control group again in the 4th week and the 8th week.
After the 8th week data collection, web-based "NIV Survival Training" will also be given to individuals in the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Identifiable Characteristics Form
Time Frame: 1 minute
|
This form, prepared by the researcher using the literature, consists of 8 questions regarding the patients' sociodemographic (age, gender, education, etc.) and clinical characteristics (disease type, etc.).
|
1 minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
S³-NIV Questionnaire
Time Frame: 3 minute
|
The questionnaire was developed to evaluate noninvasive ventilation at home. The survey consists of 10 items and two sub-dimensions. A five-point Likert scale is used to rate the items: always yes (0), mostly yes (1), sometimes yes (2), mostly no (3), completely no (4). The Cronbach alpha reliability coefficient of the survey was found to be 0.77. Score of the survey total and sub-dimensions; It is obtained by taking the average of the total score of the items and multiplying the result by 2.5. The lowest possible score (0) corresponds to the highest impact of disease and treatment, while the highest possible score (10) corresponds to the lowest impact of disease and treatment. |
3 minute
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
insomnia severity index
Time Frame: 5 minute
|
This scale, developed to determine the severity of insomnia, is used in normal population screening and clinical evaluation of insomnia. 7 items and two subscales It is a 5-point Likert type scale. Each item is scored between 0 and 4, and the total score varies between 0-28 points. Scores of 0-7 on the scale indicate clinically insignificant insomnia, 8-14 indicates mild insomnia, 15-21 indicates moderate insomnia, and 22-28 indicates severe insomnia. The internal consistency coefficient of the scale was found to be 0.79. |
5 minute
|
|
Expected behavioral changes in the individual survey
Time Frame: 1 minute
|
It was developed by the researcher to evaluate 6 behaviors that are expected to change and develop in individuals in 8 weeks as a result of web-based training.
|
1 minute
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Şahabettin ERİŞ, MScN, Study Principal Investigator
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Web-based education
-
KTO Karatay UniversityCompleted
-
Siirt UniversityInonu UniversityCompletedDisability Physical | Genital InfectionTurkey
-
Istanbul University - CerrahpasaCompletedCervical CancerTurkey
-
Inonu UniversityCompletedEducation | NursingTurkey
-
Karamanoğlu Mehmetbey UniversityKaradeniz Technical UniversityNot yet recruiting
-
Yuzuncu Yıl UniversityRecruiting
-
Yuzuncu Yıl UniversityCompletedBreastfeedingTurkey
-
Near East University, TurkeyCompletedDiabetes Mellitus, Type 2Turkey
-
Weill Medical College of Cornell UniversityWithdrawnAlzheimer Disease | Alzheimer Disease, Late Onset | Memory Loss | Patient Education as TopicUnited States
-
Ankara Yildirim Beyazıt UniversityCompleted